We strive to enhance the lives of cancer patients across the globe with our range of high quality medicines at affordable pricing.
Finished Dosage Formulations (FDF)
Globela is a leading manufacturer of FDF (finished dosage formulations) pharmaceutical products. Our FDFs are some of the best in the market due to their high quality, safety and efficacy levels and consistent performance.
A finished dosage formulations (FDF) is a pharmaceutical product that is a finalized drug ready for consumption. Drug formulations available are tablets, capsules, dry syrups and pellets.
We design and manufacture effervescent tablets that have a pleasant taste, even if they contain bitter, sulfuric, sour, metallic, astringent, or difficult-to-process APIs.
Effervescent tablets dissolve quickly in water and have rapid action. The active compound of the drug becomes available in the solution, hence increasing its absorption in the system. It increases a patient’s liquid intake and bypasses the difficulty of swallowing large pills.
All our effervescent products dissolve quickly and completely leaving no residues or foam and are very stable, being less sensitive to humidity and high temperatures and can be used in tropical regions (climatic zones III- IV).
Globela’s commitment to quality and sustainability has made us a trusted name in the industry for various Therapeutic areas.
Therapeutic Areas
DC Granules and Pellets
DC Granules and Pellets intermediate between API and Finished formulations, can be used to make both single-compound tablets and tablets with multiple ready-to-fill DC Granules or Pellets.
Procuring DC granules and Pellets from Globela, saves a lot of time for our customers by making it easy to register and put products on the market quickly without having to invest in expensive product development.
Outsourcing DC granules also helps our customers simplify their supply chain management, reduce regulatory hassles, lowers testing costs and more.
Our production facilities are WHO GMP as well EU GMP certified and are working with well established API manufacturers.
The granulation process increases the size of the particles by turning fine or coarse powders into physically strong, larger granules that are all the same shape, flow well, and can be compressed well.
We make available different DC granules each with their own particle size distribution (PSD) and concentration and outsourced as per customer requirements.
We manufacture Taste-masked granules, designed to mask the original taste of the pharma product, which may not be easy to ingest. Taste-masked granules increase a medicine acceptance rate in the patients.
We also manufacture Pellets, the multiparticulate formulations created by the agglomeration of fine powdered excipients and drugs into small, free flowing, uniformly sized spheroids or semi spherical particles in various sizes as per the requirements.
We strive to bring to you the granules and pellets of effective quality, efficient timelines and optimum rates, always.
API & Intermediates
API (Active Pharmaceutical Ingredient) refers to the active ingredient in a drug that is responsible for its therapeutic effect. API is typically produced by pharmaceutical companies and then sold to other companies that formulate and manufacture the final drug product.
The API is the main component of the drug and is often the most expensive and difficult to produce and develop.
Intermediates, on the other hand, are compounds that are produced during the synthesis of the API. They are typically produced in large quantities and are not the final product, but rather an intermediate step in the production process. Intermediates are often used in the production of multiple API and are typically less expensive than the API itself.
Both API and intermediates being the critical components in the pharmaceutical industry, the production and handling of API and Intermediates are strictly regulated to ensure the safety and quality of the final drug products.
Services
CRAMS (Contract Research and Manufacturing Services)
From Molecule to Market, with Scientific Precision
Globela supports global innovator companies in advancing Novel Chemical Entities (NCEs)
from discovery to commercialization. With a DSIR-approved R&D centre, experienced
scientists, and stringent IPR protocols, we offer specialised CRAMS services for complex
molecules and regulated markets including the US, EU, and Japan.
We bring speed, regulatory alignment, and robust documentation to every phase — from
lab-scale custom synthesis to commercial manufacturing.
Key Capabilities:
● Synthetic route scouting and design
● Process development & optimization using DOE and QbD
● Analytical method development & genotoxic impurity validation
● HPAPI and NCE development (kg to multi-kg scale)
● Phase I–IV support and CMC documentation for filings Globela ensures confidentiality, delivery discipline, and development depth, making us a
trusted CRAMS partner worldwide.
CDMO (Contract Development & Manufacturing Organization)
Integrated Development. Compliant Manufacturing. Global Supply.
Globela offers comprehensive CDMO services across oral solid dosages (OSD) and
specialized cytotoxic formulations. Our EU GMP-certified facilities are equipped for
early-phase clinical batches and full-scale commercial production.
We combine deep formulation expertise with regulatory support and fast-track tech transfer,
helping partners scale efficiently for regulated markets.
Core Offerings:
● End-to-end development and commercial manufacturing for OSDs
● Oncology & Cephalosporin facility capabilities
● In-house granulation, coating, compression, and blister packing
● Regulatory dossier support and submission-ready documentation
● Dedicated CDMO project teams for seamless collaboration
Our flexible capacity, quality systems, and on-time execution make Globela an agile partner
for generic and differentiated product development.
Technology Transfer Services
From Lab Bench to Commercial Scale — Without Compromise
Globela offers technology transfer services for APIs, advanced intermediates, and finished dosage forms, focusing on process integrity, regulatory compliance, and manufacturing
readiness. Our teams work closely with clients to ensure that every transfer is technically sound,
risk-mitigated, and aligned with regulatory expectations across global markets.
Expertise Includes:
● Analytical method transfer and process validation
● Scale-up execution and batch record finalization
● Facility adaptation for both small and large-volume manufacturing
● QA/QC integration and documentation for global audits
● Collaborative onboarding for knowledge and tech package transfer
